Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Qiming Raises $222 Million in China RMB Venture Fund

publication date: Nov 9, 2016
Qiming Venture Partners has closed its fourth RMB fund at $222 million, which brings its assets-under-management to $2.7 billion. Earlier this year, Qiming closed a US-dollar fund at $650 million, and it now has five US-dollar and four RMB funds. Qiming, which has offices in Shanghai, Beijing, Suzhou and Hong Kong, was formed in 2006. Historically, it has invested about 40% of its capital in life science companies and had, by the beginning of 2017, invested in nearly 50 separate life science companies. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital